Atea

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Atea and other ETFs, options, and stocks.

About AVIR

Atea Pharmaceuticals, Inc. is a clinical stage company, which focuses on discovering, developing, and commercializing antiviral therapeutics. Its product pipelines include Coronaviridae, Flaviviridae, and Paramyxovirdae.

CEO

Jean-Pierre Sommadossi

CEOJean-Pierre Sommadossi

Employees

Employees59

Headquarters

Boston, Massachusetts

HeadquartersBoston, Massachusetts

Founded

2012

Founded2012

Employees

Employees59

AVIR Key Statistics

Market cap

480.40M

Market cap480.40M

Price-Earnings ratio

46.56

Price-Earnings ratio46.56

Dividend yield

—

Dividend yield—

Average volume

621.63K

Average volume621.63K

High today

$5.89

High today$5.89

Low today

$5.60

Low today$5.60

Open price

$5.74

Open price$5.74

Volume

352.40K

Volume352.40K

52 Week high

$46.91

52 Week high$46.91

52 Week low

$5.31

52 Week low$5.31

AVIR Earnings

-$0.58

$0.06

$0.70

$1.34

Q1 FY21

Q2 FY21

Q3 FY21

Q4 FY21

Q1 FY22

Q2 FY22

Q3 FY22

Estimated

— per share

Estimated— per share

Actual

Expected Nov 9, After Hours

ActualExpected Nov 9, After Hours

Atea

Why Robinhood?

Atea Pharmaceuticals, Inc. is a clinical stage company, which focuses on discovering, developing, and commercializing antiviral therapeutics. Its product pipelines include Coronaviridae, Flaviviridae, and Paramyxovirdae. Show more

AVIR Key Statistics

Atea Pharmaceuticals, Inc. is a clinical stage company, which focuses on discovering, developing, and commercializing antiviral therapeutics. Its product pipelines include Coronaviridae, Flaviviridae, and Paramyxovirdae.